Forum Discussion
Immunotherapy for er+pr+ HER2-
it's wonderful to see that there are trials for triple negative metastatic bc. Are there trials for er+pr+ HER2- happening here at all? I have just returned from the Hallwang Clinic in Germany where...
Hi Giedre, the main reason that most of the trials for immunotherapy world-wide is for Triple Negative is that we have NO targeted treatment at all. Triple Negative is aggressive, fast growing and very destructive and most often attacks the young woman and has a strong correlation to BRCA gene positive therefore research is targeting this group, particularly with immunotherapy because of this. I know that most trials in Australia with immunotherapy at the moment is for Triple Negative BC mets.